Scientific MOOCs follower. Author of Airpocalypse, a techno-medical thriller (Out Summer 2017)

Welcome to the digital era of biology (and to this modest blog I started in early 2005).

To cure many diseases, like cancer or cystic fibrosis, we will need to target genes (mutations, for ex.), not organs! I am convinced that the future of replacement medicine (organ transplant) is genomics (the science of the human genome). In 10 years we will be replacing (modifying) genes; not organs!

Anticipating the $100 genome era and the P4™ medicine revolution. P4 Medicine (Predictive, Personalized, Preventive, & Participatory): Catalyzing a Revolution from Reactive to Proactive Medicine.

I am an early adopter of scientific MOOCs. I've earned myself four MIT digital diplomas: 7.00x, 7.28x1, 7.28.x2 and 7QBWx. Instructor of 7.00x: Eric Lander PhD.

Upcoming books: Airpocalypse, a medical thriller (action taking place in Beijing) 2017; Jesus CRISPR Superstar, a sci-fi -- French title: La Passion du CRISPR (2018).

I love Genomics. Would you rather donate your data, or... your vital organs? Imagine all the people sharing their data...

Audio files on this blog are Windows files ; if you have a Mac, you might want to use VLC ( to read them.

Concernant les fichiers son ou audio (audio files) sur ce blog : ce sont des fichiers Windows ; pour les lire sur Mac, il faut les ouvrir avec VLC (

Eric Topol MD's 2.0 version is Hero 6's Baymax

"Medical Blockbuster of the Year" (Forbes):

This book already exists as a fiction, by the way... So the 2.0 version of Eric Topol MD would be... Baymax. Healthcare artist and activist Regina Holliday will love this! Baymax Will See You Now.

"On a scale from 1 to 10..."
"My hands are equipped with defibrillators...Clear."
Actually, Baymax could be quite helpful in "genomic" precision medicine... Who will build him? The IBM of health care or some MIT students, in some kind of open-source mode? Intellectual Property and Digital Rights Management are building tomorrow's empires... San Franciskyoto Side Story...

Aucun commentaire: